Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan · Delayed Price · Currency is TWD

16.95

-0.10 (-0.59%)

At close: Aug 28, 2026

Daiken Biomedical Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	2,186	1,895	1,362	1,190	884.97
Revenue Growth	34.28%	39.10%	14.45%	34.52%	-
Gross Profit	1,351	1,206	856.22	813.76	613.3
Operating Income	393.91	288.21	148.92	204.15	112.44
Net Income	424.96	337.87	106.58	160.35	90.17
Earnings Per Share	0.55	0.51	0.24	0.71	0.58
EPS Growth	34.45%	110.95%	-66.34%	23.14%	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	5,261	2,236	1,140	287.07	243.71
Total Debt	116.79	118.37	2.27	276.58	136
Net Cash (Debt)	5,144	2,118	1,137	10.49	107.71
Net Cash Growth	332.86%	86.20%	10746.37%	-90.26%	-
Net Cash Per Share	6.66	3.17	2.59	0.05	0.69

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	262.6	272.59	51.75	105.21	41.58
Capital Expenditures	-0.71	-0.39	-1.25	-	-
Free Cash Flow	261.89	272.21	50.5	105.21	41.58
Free Cash Flow Growth	22.13%	439.02%	-52.00%	153.01%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	61.79%	63.62%	62.85%	68.36%	69.30%
Operating Margin	18.02%	15.21%	10.93%	17.15%	12.71%
Pretax Margin	25.11%	22.03%	10.25%	16.41%	12.38%
Profit Margin	19.44%	17.83%	7.82%	13.47%	10.19%
FCF Margin	11.98%	14.36%	3.71%	8.84%	4.70%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.698	0.698	0.404	0.486	0.417
Dividend Per Share Growth	0%	72.88%	-16.87%	16.55%	-
Dividend Yield	4.14%	4.08%	2.44%	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PE Ratio	30.78	43.03	101.90	-	-
Forward PE	-	34.13	-	-	-
P/FCF Ratio	52.14	53.42	215.06	-	-
PS Ratio	6.25	7.67	7.97	-	-